There has been increasing interest and investment in applying genomics and related technologies to drug discovery and development. However, with the exception of a small number of well-recognized successes, much uncertainty remains about how to best leverage these tools throughout the pharmaceutical value chain.
Led by Dr. Sekar Kathiresan, MD, and other renowned leaders from Harvard Medical School and industry, this executive education program provides a unique opportunity to delve into the use of genomics in common and rare diseases, and throughout the drug discovery, development, regulatory and post-regulatory phases. Pre-work, case-based teaching and group work will ground insights in real-world applications.
Send this to a friend